AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

ZBH · NYSE · Medical - Devices

Zimmer Biomet (ZBH)

Makes joint-replacement implants and robotic systems for orthopedic surgery.

$93.75

vs last close−0.57 (−0.60%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	1,754	1,940	1,889	1,942	1,824	2,023	1,909	2,077	2,001	2,244	2,087	2,177
Cost of revenue	519	539	512	554	539	587	550	592	559	792	576	636
Gross profit	1,235	1,401	1,377	1,388	1,286	1,437	1,359	1,485	1,442	1,451	1,511	1,542
	968	1,047	1,111	1,037	1,006	1,048	1,067	1,185	1,091	1,164	1,137	1,215
Research & development	117	113	108	109	112	109	111	113	116	119	103	105
Selling, general & administrative	675	722	736	737	710	747	759	815	811	867	850	899
Other expenses	177	212	267	191	185	192	198	257	164	178	184	211
Operating income	267	354	266	351	280	389	292	300	351	288	373	326
	−47	−70	−51	−49	−49	−100	−63	−75	−72	−190	−72	−71
Interest expense	51	50	51	51	54	62	66	79	75	72	69	73
Other non-operating income	−4	19	0	−2	−5	38	−3	−4	−3	118	−3	−2
Income before tax	219	285	215	302	230	289	229	225	279	98	301	255
Income tax expense	56	−135	42	59	−19	49	47	71	48	−40	63	56
Net income from continuing operations	163	420	173	243	249	240	183	153	231	138	238	200
Other adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Net income	163	419	172	243	249	240	182	153	231	140	238	198
EPS, basic	$0.78	$2.01	$0.84	$1.18	$1.23	$1.20	$0.92	$0.77	$1.17	$0.71	$1.22	$1.03
EPS, diluted	$0.77	$2.01	$0.84	$1.18	$1.23	$1.20	$0.91	$0.77	$1.16	$0.70	$1.22	$1.03
Weighted average shares, basic	209	208	205	206	202	199	199	198	198	197	195	192
Weighted average shares, diluted	210	209	206	206	203	200	200	198	199	198	196	193
EBITDA	512	576	504	597	536	615	550	576	638	454	538	328
Depreciation & amortization	241	241	239	243	251	264	254	272	284	284	162	0
EBIT	270	335	266	353	285	351	295	304	355	170	376	328